In a previous study on the expression of hypoxia-related markers (HIF1α, HIF2α, CA9 and GLUT1) in colorectal adenocarcinomas, we found that in all tumours at least one of these proteins is immunohistochemically expressed. This evidence concerns the gene SLC2A1 and neoplasm.